<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(6)</volume><submitter>Honda C</submitter><pubmed_abstract>Tumor-infiltrating lymphocytes (TILs) are a significant prognostic factor in triple-negative breast cancer. However, the clinicopathological significance of TILs in estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer remains unclear. The purpose of the present study was to evaluate the role of TILs in the prognosis of ER-positive and HER2-negative breast cancer. A total of 65 consecutive patients with ER-positive and HER2-negative breast cancer were examined. TILs in stromal tissue (str-TILs) were graded using the International TILs Working Group criteria. The association between several clinicopathological factors and TIL grade were investigated, and the prognostic impact of TILs was compared between luminal A-like and luminal B-like </pubmed_abstract><journal>Molecular and clinical oncology</journal><pagination>252</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8521382</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.</pubmed_title><pmcid>PMC8521382</pmcid><pubmed_authors>Honda C</pubmed_authors><pubmed_authors>Kurozumi S</pubmed_authors><pubmed_authors>Horiguchi J</pubmed_authors><pubmed_authors>Yajima R</pubmed_authors><pubmed_authors>Masuda K</pubmed_authors><pubmed_authors>Fujii T</pubmed_authors><pubmed_authors>Oyama T</pubmed_authors><pubmed_authors>Shirabe K</pubmed_authors><pubmed_authors>Nakazawa Y</pubmed_authors><pubmed_authors>Ogino M</pubmed_authors><pubmed_authors>Hanna-Khalil B</pubmed_authors><pubmed_authors>Makiguchi T</pubmed_authors><pubmed_authors>Obayashi S</pubmed_authors><pubmed_authors>Katayama A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer.</name><description>Tumor-infiltrating lymphocytes (TILs) are a significant prognostic factor in triple-negative breast cancer. However, the clinicopathological significance of TILs in estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer remains unclear. The purpose of the present study was to evaluate the role of TILs in the prognosis of ER-positive and HER2-negative breast cancer. A total of 65 consecutive patients with ER-positive and HER2-negative breast cancer were examined. TILs in stromal tissue (str-TILs) were graded using the International TILs Working Group criteria. The association between several clinicopathological factors and TIL grade were investigated, and the prognostic impact of TILs was compared between luminal A-like and luminal B-like </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-04T10:55:15.233Z</modification><creation>2025-04-04T10:55:15.233Z</creation></dates><accession>S-EPMC8521382</accession><cross_references><pubmed>34671471</pubmed><doi>10.3892/mco.2021.2414</doi></cross_references></HashMap>